EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis

Kevin S Wei, Alexandra N Lim, Sophie M Cannon

AACE Clinical Case Reports · 2025-01 · 11 (1) · 66-69

DOI: 10.1016/j.aace.2024.11.002 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Clinical Case Reports, 2025-01. Verfasst von Kevin S Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Keck School of Medicine at USC, Los Angeles, California. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Thyrotoxic periodic paralysis (TPP) is a rare condition causing weakness of the lower extremities associated with significant hypokalemia. Likewise, agranulocytosis due to methimazole use is a rare occurrence. We present the first documented case of concomitant TPP and agranulocytosis from methimazole use. Case Report: A 48-year-old woman presented with sore throat, fevers, odynophagia, and sudden-onset bilateral leg weakness. Methimazole had been started 10 weeks prior for a new diagnosis of Graves' disease. On admission, the patient was febrile, tachycardic, thyrotoxic, and neutropenic. She also experienced near-paralysis of the lower extremities. She was diagnosed with TPP and treated with beta blockade. She was admitted to the intensive care unit and started on broad-spectrum antibiotics, lithium, and propranolol for treatment of septic shock and hyperthyroidism, respectively. Given persistent hypokalemia despite 2 days of therapy, she was also diagnosed with refeeding syndrome.

Discussion

TPP is a rare entity, though it should be considered on the differential for any thyrotoxic patient presenting with sudden weakness. If the associated hypokalemia does not begin to normalize within 48 h of beta blockade, other etiologies should be investigated. Lastly, alternative treatments such as lithium may be used to control hyperthyroidism in patients with methimazole-induced agranulocytosis.

Conclusion

While methimazole-induced agranulocytosis and thyrotoxic periodic paralysis are independently rare diagnoses, the combination of the 2 is exceedingly rare, and our case represents the first documented case in the literature reflecting a patient suffering from both syndromes.

Schlagwörter

Stichwörter der Autor:innen

agranulocytosismethimazolethyrotoxic periodic paralysisthyrotoxicosis

Autor:innen und Institutionen

  • Department of Internal Medicine, Keck School of Medicine at USC, Los Angeles, California.
  • Division of Endocrinology, Diabetes and Metabolism, UCLA Health, Los Angeles, California.

Zitieren

APA

Wei, K. S., Lim, A. N., & Cannon, S. M. (2025). A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis. AACE Clinical Case Reports, 11(1), 66-69. https://doi.org/10.1016/j.aace.2024.11.002

Vancouver

Wei KS, Lim AN, Cannon SM. A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis. AACE Clinical Case Reports. 2025;11(1):66-69. doi:10.1016/j.aace.2024.11.002

BibTeX
@article{Wei2025,
  author = {Wei, Kevin S and Lim, Alexandra N and Cannon, Sophie M},
  title = {A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis},
  journal = {AACE Clinical Case Reports},
  year = {2025},
  volume = {11},
  number = {1},
  pages = {66--69},
  doi = {10.1016/j.aace.2024.11.002}
}
Kostenlos starten →